Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medipharm Labs Corp. (LABS.VN)

Medipharm Labs Corp. (LABS.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 648,826
  • Shares Outstanding, K 118,833
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 18.94
  • Price/Earnings ttm 23.74
  • Earnings Per Share ttm 0.23
  • Most Recent Earnings -0.01 on 03/31/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.030 +35.48%
on 07/15/19
5.650 -3.36%
on 07/22/19
+0.450 (+8.98%)
since 06/26/19
3-Month
4.030 +35.48%
on 07/15/19
7.390 -26.12%
on 05/14/19
unch (unch)
since 04/26/19
52-Week
0.910 +500.00%
on 12/05/18
7.390 -26.12%
on 05/14/19
+4.460 (+446.00%)
since 05/02/18

Most Recent Stories

More News
Shifting Cannabis Regulations Signal New Potential for the Industry

The cannabis industry experienced uplifting news after the U.S. Food and Drug Administration announced it is expediting processes to address the matter regarding cannabidiol or CBD. FDA Principal Deputy...

ACBFF : 8.6900 (-12.80%)
MEDIF : 3.0000 (-2.91%)
LABS.VN : 5.460 (+4.20%)
CRON : 6.14 (-2.23%)
CRON.TO : 8.15 (-2.51%)
ACB : 2.28 (-16.48%)
ACB.TO : 3.00 (-16.43%)
TGODF : 0.4950 (-9.14%)
TGOD.TO : 0.65 (-7.14%)
CWBHF : 10.5150 (+1.59%)
CWEB.TO : 13.88 (+1.46%)
The Cannabis Industry's Spread Worldwide Continues to Reshape Stereotypes

Cannabis has become one of the most trending topics worldwide because of its widespread legalization movements. While the plant has been heavily involved in the news cycle, cannabis has been around for...

MEDIF : 3.0000 (-2.91%)
LABS.VN : 5.460 (+4.20%)
CRON : 6.14 (-2.23%)
CRON.TO : 8.15 (-2.51%)
APHA : 3.82 (-10.12%)
APHA.TO : 5.03 (-10.97%)
OGI : 2.06 (-10.04%)
OGI.VN : 6.850 (-0.44%)
CURLF : 5.7808 (+0.68%)
CURA.CN : 7.750 (+2.24%)
First Time Users and Young Adults Choose Cannabis Over Cigarettes

Most regions around the world allow young adults at the age of 18 to enjoy or purchase their own alcohol and tobacco. However, the U.S. has strictly enforced that adults must be 21 years old or older in...

MEDIF : 3.0000 (-2.91%)
LABS.VN : 5.460 (+4.20%)
IIPR : 82.84 (-3.09%)
TLRY : 19.91 (-0.10%)
KERN : 5.21 (-12.28%)
MTEC : 11.99 (+14.19%)
PYX : 7.60 (-12.54%)
Alternative Cannabis Based Products Gain Traction in a Crowded Marketplace

The medical cannabis marketplace has been around for quite some time in the North American region. Notably, California was among the first regions to legalize medical cannabis back in the 1990s. Following...

CRFTF : 0.1200 (-9.43%)
CRFT.CN : 0.155 (-8.82%)
CRON : 6.14 (-2.23%)
CRON.TO : 8.15 (-2.51%)
LABS.VN : 5.460 (+4.20%)
MEDIF : 3.0000 (-2.91%)
APHA : 3.82 (-10.12%)
APHA.TO : 5.03 (-10.97%)
OGI : 2.06 (-10.04%)
OGI.VN : 6.850 (-0.44%)
NEPT : 2.49 (-8.12%)
NEPT.TO : 3.29 (-8.10%)
Continued Legalization Efforts Aid the Cannabis Market's Global Expansion

Cannabis has emerged as a global and disruptive market over recent year due to a group of the countries moving towards legalization. Notably, Canada's legalization of adult-use marked a historic milestone...

GWPH : 102.47 (-5.48%)
CRON : 6.14 (-2.23%)
CRON.TO : 8.15 (-2.51%)
LABS.VN : 5.460 (+4.20%)
MEDIF : 3.0000 (-2.91%)
ZYNE : 6.17 (-3.29%)
SRNE : 1.45 (-5.23%)
MediPharm Labs Receives Permits and Ships First Medical Cannabis Concentrate to Australia

MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company"), a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce...

ACNNF : 0.1570 (-6.55%)
LABS.VN : 5.460 (+4.20%)
MEDIF : 3.0000 (-2.91%)
IIROC Trading Resumption - LABS

VANCOUVER , May 29, 2019 /CNW/ - Trading resumes in:

LABS.VN : 5.460 (+4.20%)
IIROC Trading Halt - LABS

VANCOUVER , May 28, 2019 /CNW/ - The following issues have been halted by IIROC:

LABS.VN : 5.460 (+4.20%)
UPDATE - New York City Icahn School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study And "CBD International Consortium" to Develop Treatment of Opioid Addiction

MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE:MLZ) ("MediPharm Labs") a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce it has been...

LABS.VN : 5.460 (+4.20%)
MEDIF : 3.0000 (-2.91%)
Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million

MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) ("MediPharm Labs") a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce that it has entered into...

LABS.VN : 5.460 (+4.20%)
MEDIF : 3.0000 (-2.91%)
CRON : 6.14 (-2.23%)
CRON.TO : 8.15 (-2.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 5.707
1st Resistance Point 5.583
Last Price 5.460
1st Support Level 5.233
2nd Support Level 5.007

See More

52-Week High 7.390
Last Price 5.460
Fibonacci 61.8% 4.915
Fibonacci 50% 4.150
Fibonacci 38.2% 3.385
52-Week Low 0.910

See More

Business Summary

MediPharm Labs Corp has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulation without first receiving a cannabis cultivation license. The focus on cannabis concentrates from current Good...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar